Trxade Group, Inc. (MEDS)
|Net Income (ttm)||-2.54M|
|Trading Day||April 16|
|Day's Range||4.60 - 4.90|
|52-Week Range||4.02 - 8.25|
Trxade Group to Report First Quarter 2021 Financial Results on Monday, April 26th at 5:00 p.m. Eastern Time
TAMPA, FL / ACCESSWIRE / April 12, 2021 / Trxade Group, Inc. (NASDAQ:MEDS) , a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the presc...
CEO Suren Ajjarapu to Present Wednesday, April 21st, 2021 TAMPA, FL / ACCESSWIRE / April 9, 2021 / Trxade Group, Inc. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharm...
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform
Trxade Group to Report Fourth Quarter and Full Year 2020 Results on Monday, March 29th at 5:00 p.m. Eastern Time
TAMPA, FL / ACCESSWIRE / March 15, 2021 / Trxade Group, Inc. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the pr...
TAMPA, FL / ACCESSWIRE / March 5, 2021 / Trxade Group, Inc. (NASDAQ:MEDS), a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience, today announced t...
TAMPA, FL, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc. ( MEDS ) an integrated drug procurement, delivery and healthcare platform, today announced that management will present at the Diamond Equ...
Shares of Trxade Group Inc. soared 56% in active trading to pace all of the premarket's gainers Tuesday, after the online platform for pharmaceutical purchases announced a market program agreement with ...
Trxade Group, Inc., together with its subsidiaries, operates a business-to-business (B2B) web-based marketplace focused on the pharmaceutical industry in the United States. It operates through Trxade, Inc.; Community Specialty Pharmacy, LLC; Integra Pharma, LLC; and Other segments. The company operates a web-based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com, a web-based pharmaceutical marketplace; InventoryRx.com, ... [Read more...]
|IPO Date |
Feb 13, 2020
|Stock Exchange |
|Ticker Symbol |
In 2020, Trxade Group's revenue was $17.12 million, an increase of 130.26% compared to the previous year's $7.44 million. Losses were -$2.54 million, 791.6% more than in 2019.
According to 3 analysts, the average rating for Trxade Group stock is "Buy." The 12-month stock price forecast is 11.50, which is an increase of 141.09% from the latest price.